秘鲁关于伊维菌素和COVID-19的纪录片
TrialSite新闻制作
介绍了关于秘鲁的新纪录片特刊COVID-19，并接受了依维菌素作为正式批准的新型冠状病毒治疗的接受。
由TrialSite签约的秘鲁电影摄制组在秘鲁拍摄，
纪录片
受委托帮助世界其他地方更好地了解
为什么秘鲁及周边地区
已成为社区医生运动的中心，该运动倡导在标签上使用依维菌素治疗COVID-19患者。
why Peru and the surrounding region
have become an epicenter for a community physician movement that advocated for the off-label use of Ivermectin to treat COVID-19 patients.
Many doctors there in the South American nation swear by it.
In fact, some of them
cursed the government for not embracing it sooner while other doctors are vehemently opposed to the use of the anti-parasitic drug for COVID-19—at least until there is more actual evidence of its efficacy.
Watch this original TrialSite production to learn how Ivermectin became popular in Peru as an Ivermectin treatment.
What is the basis and justification for its use?
Have formal clinical trials been undertaken there?
Why are many physicians fervently pro-use while others adamantly opposed?
What is going on with self-treatment and why does that represent trouble in Peru?
What is the path forward for Ivermectin as a COVID-19 treatment in Peru?
This South American country
might just portend the future for other low-to-middle-income countries as they seek pragmatic ways to battle the novel coronavirus.
TrialSite News Original |